Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique

被引：0

作者：

Bonny Parkinson

Sallie-Anne Pearson

Rosalie Viney

机构：

[1] University of Technology,Centre for Health Economics Research and Evaluation (CHERE)

[2] Sydney,Pharmacoepidemiology and Pharmaceutical Policy Research Group, Faculty of Pharmacy

[3] The University of Sydney,undefined

来源：

The European Journal of Health Economics | 2014年 / 15卷

关键词：

Economics; Cost-utility analysis; Cost-effectiveness analysis; Breast neoplasms; Metastatic; Trastuzumab; I18; D61;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：93 / 112

页数：19

共 50 条

[1] Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique
Parkinson, Bonny
Pearson, Sallie-Anne
Viney, Rosalie
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (01): : 93 - 112
[2] Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
Jeyakumar, Alwin
Younis, Tallal
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
[3] Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
Nie, Tina
Blair, Hannah A.
TARGETED ONCOLOGY, 2023, 18 (03) : 463 - 470
[4] Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
Tina Nie
Hannah A. Blair
Targeted Oncology, 2023, 18 : 463 - 470
[5] A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer
Petrou, Panagiotis
BREAST JOURNAL, 2020, 26 (09): : 1903 - 1905
[6] Trastuzumab emtansine in HER2-positive metastatic breast cancer
Montemurro, Filippo
LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
[7] Trastuzumab therapy in HER2-positive, metastatic breast cancer
Smith, A. D.
Guilbert, K.
Lister, D.
Streilein, S.
Bourrier, V. C.
Lozar, B.
Navaratnam, S.
Harding, G. A.
Pitz, M. W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[8] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
Lorenz, Judith
GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
[9] Trastuzumab deruxtecan, its efficacy in patients with metastatic HER2-positive breast cancer: a systematic review
Fernhandho, V.
Jhoputri, C. Fricilia
Julian, L.
Kurniawan, A.
Huang, I.
ANNALS OF ONCOLOGY, 2024, 35 : S1337 - S1337
[10] Looking for Her (2+): A systematic review of the economic evaluations of Trastuzumab in early stage HER 2 positive breast cancer
Petrou, Panagiotis
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (02) : 115 - 125

← 1 2 3 4 5 →